Cases & Deals

  • Home
  • Practices
  • CDC Innovation and GrowthWorks Capital complete sale of Praxim to Orthopaedic Synergy

Share

CDC Innovation and GrowthWorks Capital complete sale of Praxim to Orthopaedic Synergy

May 2010

Client(s) CDC Innovation

Jones Day provided advice to CDC Innovation and GrowthWorks Capital, as selling shareholders, in the sale of Praxim S.A., a developer of automated systems, software, and instruments used by surgeons to make total joint arthroplasty less-invasive, to Orthopaedic Synergy, Inc., a holding company for OMNIlife Science, Inc. and Enztec, Ltd. which are companies that design, manufacture, and distribute high quality orthopaedic devices. The sale and the continuation plan of Praxim were subject to the approval of the bankruptcy court of Grenoble.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.